Contact Information
Company Information
Company
Triumvira Immunologics
Total Funding
124742729.0
Technologies
Outlook
Google Cloud Hosting
BugHerd
Vimeo
Google Tag Manager
WordPress.org
Typekit
Mobile Friendly
reCAPTCHA
Bootstrap Framework
YouTube
Nginx
Viewpoint
Keywords
immunology
oncology
cell & gene therapy
t cell antigen coupler
clinical developement
partnerships
biotechnology research
t cell therapy
immunotherapy
tac technology
autologous t cells
allogeneic t cells
car-t
tcr therapy
cancer treatment
tumor targeting
tumor antigen recognition
liquid tumors
solid tumors
clinical trials
antigen coupler
cell therapy
cell manufacturing
gamma delta t cells
t cell activation
immune response enhancement
tumor microenvironment
side effect reduction
anti-tumor response
immune system activation
tumor cell killing
t cell persistence
safety profiles
preclinical studies
pipeline development
biotechnology
phd research
receptor targeting
genetic engineering
t cell receptor
biopharmaceuticals
healthcare innovation
disease management
patient-derived therapy
biologic therapies
pharmaceutical development
clinical efficacy
anti-cancer therapies
cell culture
novel therapeutics
treatment paradigms
healthcare investment
collaborative research
healthcare partnerships
clinical data
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans